We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Merck

Merck Serono (Ireland) Limited, 4045 Kingswood Road, Citywest Business Campus, Dublin 24, Ireland
Telephone: +353 1 468 7590
Fax: +353 1 466 3446
Medical Information Direct Line: +44 (0)208 818 7373
Medical Information e-mail: medinfo.uk@merckgroup.com
Medical Information Facsimile: +44 (0)208 818 7274
Summary of Product Characteristics last updated on medicines.ie: 18/12/2017
SPC MAVENCLAD 10mg tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 18/12/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 10 - Date of revision of the text
Date of revision of text on the SPC:   01-Dec-2017
Legal Category:   Product subject to medical prescription which may be renewed (B)

Free-text change information supplied by the pharmaceutical company

$0- In section 5.1 (Pharmacodynamic properties), text has been changed to  Pharmacotherapeutic group: SelectiveImmunosuppressants, ATC code:  L04AA40.$0$0- In section 10 (Date of revision of the text),  has changed to 12/2017. $0
Updated on 11/09/2017 and displayed until 18/12/2017
Reasons for adding or updating:
  • New SPC for new product
Date of revision of text on the SPC:  
Legal Category:   Product subject to medical prescription which may be renewed (B)

Free-text change information supplied by the pharmaceutical company

None provided

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Cladribine